ScholarIQanswers from OpenAlex

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

PaperCitations, authors & open-access status

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours have?

ScholarIQcitation count

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours has 572 citations in the OpenAlex counts ScholarIQ stores.

When was Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours published?

ScholarIQyear

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours has 2019 year in the ScholarIQ index.

What is the open-access status of Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours?

ScholarIQoa status

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours has closed oa status in the ScholarIQ index.

What is the DOI of Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours?

ScholarIQdoi

The DOI for Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours is on the source record.

What is the PMID of Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours?

ScholarIQpmid

The PMID for Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours is on the source record.

What is the OpenAlex record for Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours?

ScholarIQopenalex

The OpenAlex for Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial